LUNAI BIOWO. O.N.

LUNAI BIOWO. O.N.

Share · US29350E2037 · LNAI · A41K8P (XNCM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of LUNAI BIOWO. O.N.
No Price
29.04.2026 08:59
Current Prices from LUNAI BIOWO. O.N.
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
LNAI
USD
29.04.2026 08:59
0,32 USD
-0,02 USD
-5,80 %
IEXG: IEX
IEX
LNAI
USD
28.04.2026 19:41
0,33 USD
0,03 USD
+8,49 %
Share Float & Liquidity
Free Float 55,78 %
Shares Float 9,93 M
Shares Outstanding 17,8 M
Company Profile for LUNAI BIOWO. O.N. Share
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.

Company Data

Name LUNAI BIOWO. O.N.
Company Lunai Bioworks Inc.
Symbol LNAI
Website https://renovarogroup.com
Primary Exchange XNCM Frankfurt
WKN A41K8P
ISIN US29350E2037
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO David H. Weinstein
Market Capitalization 33 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 2080 Century Park East, 90067 Los Angeles
IPO Date 2025-09-30

Stock Splits

Date Split
30.09.2025 1:10

ID Changes

Date From To
01.10.2025 RENB LNAI
07.08.2023 ENOB RENB
22.03.2018 DDRT ENOB

Ticker Symbols

Name Symbol
Frankfurt 2Q50.F
NASDAQ LNAI
More Shares
Investors who hold LUNAI BIOWO. O.N. also have the following shares in their portfolio:
DEERE + CO 19/49
DEERE + CO 19/49 Bond
HERA 20/30 MTN
HERA 20/30 MTN Bond